diclofenac has been researched along with aspartic acid in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (71.43) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Rainsford, KD; Whitehouse, MW | 1 |
Flanagan, JU; McLaughlin, LA; Paine, MJ; Roberts, GC; Sutcliffe, MJ; Wolf, CR | 1 |
Dickmann, LJ; Jones, JP; Locuson, CW; Rettie, AE | 1 |
Halliwell, B; Ng, LE; Vincent, AS; Wong, KP | 1 |
Barbarić, M; Filipović-Grcić, J; Husnjak, I; Kralj, M; Marjanović, M; Pavelić, K; Zorc, B; Zorc, D | 1 |
7 other study(ies) available for diclofenac and aspartic acid
Article | Year |
---|---|
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption | 2007 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Non-steroid anti-inflammatory drugs: combined assay for anti-edemic potency and gastric ulcerogenesis in the same animal.
Topics: Acacia; Adjuvants, Pharmaceutic; Animals; Aspartic Acid; Aspirin; Carrageenan; Diclofenac; Drug Evaluation, Preclinical; Edema; Female; Glucose; Glycyrrhiza; Male; Phenylacetates; Plants, Medicinal; Pyrroles; Rats; Salicylates; Stomach Ulcer; Tolmetin | 1977 |
Role of conserved Asp293 of cytochrome P450 2C9 in substrate recognition and catalytic activity.
Topics: Amino Acid Sequence; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antitussive Agents; Aryl Hydrocarbon Hydroxylases; Aspartic Acid; Cytochrome P-450 CYP2C9; Dextromethorphan; Diclofenac; Humans; Hypoglycemic Agents; Models, Molecular; Molecular Sequence Data; Molecular Structure; Mutagenesis, Site-Directed; NADPH-Ferrihemoprotein Reductase; Protein Binding; Protein Structure, Secondary; Rabbits; Sequence Alignment; Substrate Specificity; Tolbutamide | 2003 |
Differential roles of Arg97, Asp293, and Arg108 in enzyme stability and substrate specificity of CYP2C9.
Topics: Amino Acid Substitution; Arginine; Aryl Hydrocarbon Hydroxylases; Aspartic Acid; Binding Sites; Cytochrome P-450 CYP2C9; Diclofenac; Enzyme Stability; Gene Expression; Histidine; Humans; Kinetics; Models, Molecular; Mutagenesis; Pyrenes; Substrate Specificity; Warfarin | 2004 |
Action of diclofenac on kidney mitochondria and cells.
Topics: Acute Kidney Injury; Adenosine Triphosphate; Animals; Aspartic Acid; Benzimidazoles; Carbocyanines; Cells, Cultured; Diclofenac; Dogs; Glutamate Dehydrogenase; Kidney; Malate Dehydrogenase; Malates; Membrane Potentials; Mitochondria; Mitochondrial Membranes; NADH Dehydrogenase; Oligomycins; Rats | 2006 |
Synthesis and in vitro antitumor effect of diclofenac and fenoprofen thiolated and nonthiolated polyaspartamide-drug conjugates.
Topics: Antineoplastic Agents; Aspartic Acid; Cell Line, Tumor; Diclofenac; Drug Carriers; Drug Screening Assays, Antitumor; Fenoprofen; Humans; Nylons; Prodrugs; Structure-Activity Relationship; Sulfhydryl Compounds | 2007 |